To identify a cellular model on which to study the impact of anti-PD-1 therapy on miRNA methylation levels, we analyzed PD-1 expression on the surface of a panel of four lung cancer cell lines (A549, H1975, HT358, and HT1650). The gene discussed is PDCD1; the disease is lung carcinoma.